REFERENCES
- Shields CL, Mashayekhi A, Cater J, Chemoreduction for retinoblastoma: analysis of tumor control and risks for recurrence in 457 tumors. Trans Am Ophthalmol Soc. 2004;102:35–45.
- Shields CL, Shields JA. Diagnosis and management of retinoblastoma. Cancer Control. 2004;11:317–327.
- Shields CL, Mashayekhi A, Demirci H, Practical approach to management of retinoblastoma. Arch Ophthalmol. 2004;122:729–735.
- Chantada GL, Fandino AC, Raslawski EC, Experience with chemoreduction and focal therapy for intraocular retinoblastoma in a developing country. Pediatr Blood Cancer. 2005;44:455–460.
- Chantada G, Fandino A, Davila MTG, Results of a prospective study for the treatment of retinoblastoma. Cancer. 2004;100:834–842.
- Rodriguez-Galindo C, Wilson MW, Haik BG, Treatment of intraocular retinoblastoma with vincristine and carboplatin. J Clin Oncol. 2003;21:2019–2025.
- Shields CL, Shields JA, Needle M, Combined chemoreduction and adjuvant treatment for intraocular retinoblastoma. Ophthalmology. 1997;104:2101–2111.
- Shields CL, De Potter P, Himelstein BP, Chemoreduction in the initial management of intraocular retinoblastoma. Arch Ophthalmol. 1996;14:1330–1338.
- Sussman DA, Escalona-Benz E, Benz MS, Comparison of retinoblastoma reduction for chemotherapy vs external beam radiotherapy. Arch Ophthalmol. 2003;121:979–984.
- Ghose S, Nizamuddin SH, Sethi A, Efficacy of induction chemotherapy in retinoblastoma, alone or combined with other adjuvant modalities. J Pediatr Ophthalmol Strabismus. 2002;39:143–150.
- Murphree AL, Villablanca JG, Deegan WF, 3rd, Chemotherapy plus local treatment in the management of intraocular retinoblastoma. Arch Ophthalmol. 1996;114:1348–1356.
- Chantada GL, Dunkel IJ, Abramson DH. Management of high risk retinoblastoma. Expert Rev Ophthalmol. 2012;7:61–72.
- Friedman DL, Himelstein B, Shields CL, Chemoreduction and local ophthalmic therapy for intraocular retinoblastoma. J Clin Oncol. 2000;18:12–17.
- Murphree AL. Intraocular retinoblastoma: the case for a new classification. Ophthalmol Clin N Am. 2005;18:41–53.
- Shields CL, Mashayekhi A, Cater J, Chemoreduction for retinoblastoma. Analysis of tumor control and risks for recurrence in 457 tumors. Am J Ophthalmol. 2004;138:329–337.
- Peto R, Pike MC, Armitage P, Design and analysis of randomized clinical trials requiring prolonged observation of each patient. II. Analysis and examples. Br J Cancer. 1977;35:1–39.
- Gündüz K, Günalp I, Yalçındağ N, Causes of chemoreduction failure in retinoblastoma and analysis of associated factors leading to eventual treatment with external beam radiotherapy and enucleation. Ophthalmology. 2004;111:1917–1924.
- Shields CL, Meadows AT, Leahey AM, Shields JA. Continuing challenges in the management of retinoblastoma with chemotherapy. Retina. 2004;24:849–862.
- Shields CL, Shelil A, Cater J, Development of new retinoblastomas after 6 cycles of chemoreduction for retinoblastoma in 162 eyes of 106 consecutive patients. Arch Ophthalmol. 2003;121:1571–1576.
- Chantada GL, Fandino AC, Guitter MR, Results of a prospective study for the treatment of unilateral retinoblastoma. Pediatr Blood Cancer. 2010;55:60–66.
- Shields CL, Honavar SG, Shields JA, Factors predictive of recurrence of retinal tumors, vitreous seeds, and subretinal seeds following chemoreduction for retinoblastoma. Arch Ophthalmol. 2002;120:460–464.
- Shields CL, Shields JA, Cater J, Plaque radiotherapy for retinoblastoma: long-term tumor control and treatment complications in 208 tumors. Ophthalmology. 2001;108:2116–2121.
- Shields CL, Santos MC, Diniz W, Thermotherapy for retinoblastoma. Arch Ophthalmol. 1999;117:885–893.
- Schiavetti A, Hadjistilianou T, Clerico A, Conservative therapy in intraocular retinoblastoma: response/recurrence rate. J Pediatr Hematol Oncol. 2005;27:3–6.
- Zage PE, Reitman A, Seshadri R, Outcomes of a two-drug chemotherapy regimen for intraocular retinoblastoma. Pediatr Blood Cancer. 2008;50:567–572.
- Kebudi R, Ayan İ, Cantürk Ş, Chemoreduction and local ophthalmic therapies in intraocular retinoblastoma. Pediatr Blood Cancer. 2007;49:485.
- Leal-Leal C, Flores-Rojo M, Medina-Sanson A, A multicentre report from the Mexican Retinoblastoma Group. Br J Ophthalmol. 2004;88:1074–1077.
- Zhao J, Dimaras H, Massey C, Pre-enucleation chemotherapy for eyes severely affected by retinoblastoma masks risk of tumor extension and increases death from metastasis. J Clin Oncol. 2011;29:845–851.
- Chantada G, Leal-Leal C, Brisse H, Is it pre-enucletiaon chemotherapy or delayed enucleation of severely involved eyes with intraocular retinoblastoma that risks extraocular dissemination and death? J Clin Oncol. 2011;29:3333–3334.